New study reveals novel multi-omics approach with unprecedented treatment response prediction in metastatic urothelial cancer

FHS
March 13, 2025
10:21 am

Novigenix, a leader in AI-driven healthcare solutions, has published a groundbreaking study showcasing the predictive power of its LITOSeek™ platform for immunotherapy response in metastatic urothelial cancer.

Roivant strikes another deal, selling dermatology spinoff to Organon in deal worth $1.2 billion

Roivant Sciences continues its dealmaking hot streak, announcing Wednesday that it would sell one of its subsidiaries to pharma company Organon in a deal worth

September 18, 2024

Morris & Dickson will distribute mpox vaccine Jynneos in the US – Pharmaceutical Technology

Share this article Jynneos was a driver of Bavarian Nordic’s 2023 revenue surge. Credits: Richard H Grant/Shutterstock.com Following Bavarian Nordic’s announcement of the US commercial

April 3, 2024

Biden administration boosts some Medicaid payments to match commercial rates

You’re reading the web version of Health Care Inc., STAT’s weekly newsletter following the flow of money in medicine. Sign up to get it in

April 29, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.